DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Hauber AB, Johnson FR, Grotzinger KM, Ozdemir S.
Patients' benefit-risk preferences for chronic idiopathic thrombocytopenic purpura therapies.
Ann Pharmacother 2010;
44 (3) 479-488
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.